Email this article The indicators of the tumour proliferative activity and therapeutic responsiveness in adenocarcinoma in anal canal after complex treatment
- Authors: Zenukova T.V.1, Perevoschikov A.G1, Kuzmichev D.V1, Barsukov Y.A1
-
Affiliations:
- Blokhin Research Center Russian Cancer of the Russian Academy of Medical Sciences
- Issue: Vol 19, No 5 (2014)
- Pages: 42-46
- Section: Articles
- URL: https://journals.rcsi.science/1028-9984/article/view/40119
- DOI: https://doi.org/10.17816/onco40119
- ID: 40119
Cite item
Full Text
Abstract
Carcinoma of the anal canal is infrequent pathology. The morbidity registers in 5,2% among men and 4,8% among women. The purpose of this study was investigated the correlation among morphological characteristics of the tumors. Tumor regression grade and index Ki 67 are morphological indicators of the effectiveness of the complex treatment. In the 47,5% (n = 19) of both groups was exposed I-II tumour regression grade, IV tumour regression in grade 3,3 % (n = 2). Tumor regression grade positively correlated with the degree of the tumor invasion (coeff.corr. = +0,47) (p > 0.05).
Full Text
##article.viewOnOriginalSite##About the authors
Tat’yana V. Zenukova
Blokhin Research Center Russian Cancer of the Russian Academy of Medical Sciences
Email: zenyukova1980@mail.ru
МD 115478 Moscow, Russian Federation
A. G Perevoschikov
Blokhin Research Center Russian Cancer of the Russian Academy of Medical Sciences115478 Moscow, Russian Federation
D. V Kuzmichev
Blokhin Research Center Russian Cancer of the Russian Academy of Medical Sciences115478 Moscow, Russian Federation
Yu. A Barsukov
Blokhin Research Center Russian Cancer of the Russian Academy of Medical Sciences115478 Moscow, Russian Federation
References
- Делекторская В.В., Кушлинский Н.Е. Нейроэндокринные опухоли пищеварительной системы: морфологический спектр и клеточная пролиферация (индекс Ki67). Вестник РАМН. 2013; 5: 28-34.
- Каприна А.Д., Старинский В.В., Петрова Г.В., ред. Злокачественные новообразования в России в 2012 году. М.: ФГБУ «МНИОИ им. П.А. Герцена» Минздрава России; 2014.
- Ким Д.Ф. Комплексное лечение пациентов с пло скоклеточным раком анального канала. Онкологическая колопроктология. 2012; 9: 14.
- Кныш В.И. Тимофеев Ю.М. Злокачественные опухоли анального канала. М.; 1997.
- Барсуков Ю.А. Колоректальный рак с синхронными отдаленными метастазами: обоснование циторедуктивных операций и перспективы - взгляд хирурга. Онкологическая колопроктология. 2012; 4: 15-21.
- Mars C.M., Kurtz J.M. Impact of clinical and therapeutical factors on major late. Int. Radiat. Oncol. Biol. Phys. 1997; 39(5): 1099-105.
- Lester S.C., Bose Sh., Yunn-Yi Chen, Connolly J.L., Baca M.E., Fitzgibbons P.L. et al. Protocol for the examination of specimens patients with invasive carcinoma of the breast. Arch. Pathol. Lab. Med. 2009; 133: 1515-38.
- Горбань Н.А. Клинико-морфологическая и иммуногисто-химическая характеристика и прогностические критерии плоскоклеточного рака гортани. Обнинск; 2008.
- Кузнецова М.Е. Иммуногистохимическая оценка эффективности лучевой терапии местнораспространенного рака шейки матки. Сибирский онкологический журнал. 2008; Прил. № 1: 74-5.
- Forones N.M., Carvalho A.P. Jiannotti-Filho O. et al. Cell proliferation and apoptosis in gastric cancer and intestinal metaplasia. Arq. Gastroenterol. 2005; 42(1): 30-4.
- He X., Chen Z., Fu T., Jin X., Yu T., Liang Y., Zhao X., Huang L. Ki-67 is valuable prognostic predictor of lymphoma but its utility varies in lymphoma subtypes:evidence from a systematic metaanalysis. BMC Cancer. 2014; 14: 153.
- Lampejo T., Kavanagh D., Clark J., Goldin R., Osborn M., Ziprin S. Prognostic biomarkers in squamous cell carcinoma of the anus: a systematic review. Br. J. Cancer. 2010; 103(12): 1858-69.
- Jacob C., Liersch T., Meyer W., Becker H., Baretton G.B., Aust D.K. Predictive value of Ki67 and p53 in locally advanced rectal cancer. Correlation with thymidylatesynthase and histopathological tumour regression after neoadjuvant 5-FU-based chemoradiotherapy. World J. Gastroenterol. 2008; 14(7): 1060-6.
- Allal A.S., Mermillod B., Roth A.D., Marti M.C., Kurtz J.M. Impact of clinical and therapeutic factors on major late complications after radiotherapy with or without concomitant chemotherapy for anal carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 1997; 39(5): 1099-105.
- Горбань Н.А., Кудайбергенова А.Г., Панкратов В.А. Прогностическое значение маркеров пролиферативной активности в регуляции апоптоза при плоскоклеточном раке гортани. Архив патологии. 2013; 75(1): 3-9.
- Xiao L.J., Zhao S., Zhao E.H., Zheng X., Gou W.F., Takano Y., Zheng H.C. Clinicopathological and prognostic significance of Ki-67, caspase-3 and p53 expression in gastric carcinomas. Oncol Lett. 2013; 6(5): 1277-84.
- Wu A., Jia Y., Dong B., Tang L., Liu Y., Du H. et al. Apoptosis and KI 67 index correlate with preoperative chemotherapy efficacy and better predict the survival of gastric cancer patients with combined therapy. Cancer Chemother. Pharmacol. 2014; 73(5): 885-93.
